Malaria Vaccine Technology Roadmap
Defining Promising Pathways to a Viable Vaccine
Vision Meeting

Roadmap Meeting
Stakeholder Meetings
Roadmap Factsheet
Background Materials
RoadMap Participants
Contacts
Message Board
Upcoming Meetings





Malaria Vaccine Technology Roadmap Participants

The following individuals participated in the Malaria Vaccine Technology Roadmap process. In total, more than 230 people representing more than 100 organizations in 35 countries provided their input to the Roadmap process.

First Name Last Name Company
John Adams University of Notre Dame
Olusoji Adeyi World Bank
Martin Adjuik Navrongo Health Research Centre
Susan Adu-Amankwah Noguchi Memorial Institute for Medical Research
George Akanbu Naval Health Research Center
Onome Akpogheneta London School of Hygiene & Tropical Medicine
Patricia Akweongo Navrongo Health Research Centre
Ali Alloueche Chiron Vaccines
Pedro Alonso Hospital Clinic, University of Barcelona & CISM Mozambique
Evelina Angov Walter Reed Army Institute of Research
Thomas Anthony London School of Hygiene & Tropical Medicine
Kwadwo Odei Antwi-Agyei Expanded Programme on Immunization, Ghana Health Service
Thomas Anyorigiya Navrongo Health Research Centre
Ripley Ballou GlaxoSmithKline Biologicals
William Bancroft SAIC
John Barnwell Centers for Disease Control
Julia Barrett Biologics Consulting Group
Dror Baruch U.S. National Institutes of Health
Hasan Basri NAMRU 2
Girindre Beeharry Bill & Melinda Gates Foundation
Peter C.L. Beverley The Edward Jenner Institute for Vaccine Research
Ted Bianco The Wellcome Trust
Fred Binka Indepth-Network
Ruth Branston The Wellcome Trust
Joel Breman Fogarty International Center
Ross Brindle Energetics, Inc.
Alan Brooks The PATH Malaria Vaccine Initiative
Graham Brown University of Melbourne
Joe Bruder GenVec
Daniel Carucci Foundation for NIH
Marina Chavchich AMI/QIMR
Chetan Chitnis International Centre for Genetic Engineering and Biotechnology
Watcharee Chokejindachai London School of Hygiene & Tropical Medicine
Joe Cohen GlaxoSmithKline Biologicals
Martin Comberbach GeneMedix plc
David Conway MRC Gambia
Ross Coppel Monash University
Karen Cowgill London School of Hygiene & Tropical Medicine
Brendan Crabb The Walter & Eliza Hall Institute
Jakob Peter Cramer Bernhard-Nocht-Institute for Tropical Medicine
Christopher Curtis London School of Hygiene & Tropical Medicine
Jon Daugherty U.S. Food and Drug Administration
Eugene Davidson Georgetown University
Karen Day NYU School of Medicine
Don de Savigny Swiss Tropical Institute
Charles de Taisne Sanofi Pasteur
Steven Derrick U.S. FDA Center for Biologics Evaluation and Research
Carter Diggs U.S. Agency for International Development
Daniel Dodoo Noguchi Memorial Institute
Paget Donnelly Energetics Incorporated
Denise Doolan Naval Medical Research Center
Ogobara Doumbo University of Mali
Pierre Druilhe Pasteur Institute
Filip Dubovsky The PATH Malaria Vaccine Initiative
Susanna Dunachie Oxford University
Kenneth Eckels Walter Reed Army Institute of Research
Robert Edelman University of Maryland
Jack Eisenhauer Energetics Incorporated
Ahmed El Tahir University of Gezira
Mwageni Eleuther Rufiji DSS
Bill Enright GenVec, Inc.
Judith Epstein NMRC
Sarah Ewart The PATH Malaria Vaccine Initiative
Alex Ezeh African Population and Health Research Center
Bernard Fanget Flamel Technologies
Andrew Farlow Oxford University
Michelle Folsom Partnership for Appropriate Technology in Health 
Julia Fox-Rushby Health Economics Research Group, Brunel University
Martin Friede World Health Organization
Edward Galiwango Iganga DSS - Uganda
Blaise Genton Swiss Tropical Institute
Sarah Gilbert University of Oxford
Michael Good Queensland Institute of Medical Research
Michael Gottlieb Foundation for the National Institutes of Health
Brian Greenwood London School of Hygiene and Tropical Medicine
Aric Gregson Center for Vaccine Development
Bernard Guyah WRP/KEMRI
Margaret Gyapong Dodowa Health Research Centre Ghana Health Service
Abdullahel Hadi Watch Project
Julius Hafalla New York University School of Medicine
Kasturi Haldar Northwestern University
Lee Hall National Institute of Allergy and Infectious Diseases, U.S. NIH
Andreas Heddini Multilateral Initiative on Malaria
Carole Heilman National Institute of Allergy and Infectious Diseases, U.S. NIH
D. Gray Heppner US Army
Kobus Herbst Africa Centre
Socrates Herrera International Malaria Vaccine and Drug Testing Center
Matthew Higgins University of Cambridge
Adrian Hill University of Oxford
Abraham Hodgson Navrongo Health Research Centre
Stephen Hoffman Sanaria Inc.
Anthony Holder National Institute for Medical Research
Andreas Holtel EU Commission DG RTD
Douglas Holtzman Bill & Melinda Gates Foundation
Lars Hviid Rigshospitalet
Ronald Iacocca Eli Lilly and Company
Suresh Jadhav Serum Institute of India Ltd.
Stephanie James Federation for NIH
Soren Jepsen European Malaria Vaccine Initiative 
Susan Jones Nature Reviews Microbiology
David Kaslow Vical
Moji Kazuhiko Institute of Tropical Medicine
Claire Kidgell Scripps Research Institute
Marie-Paule Kieny World Health Organization
Wen Kilama African Malaria Network Trust (AMANET)
Shirima Kizito Ifakara Health Research and Development Centre
Richard Klausner Bill & Melinda Gates Foundation
Jack Kloeber Johnson & Johnson
Kwadwo Koram Noguchi Memorial Institute
Jingyee Kou U.S. FDA Center for Biologics Evaluation and Research
Bocar Kouyate Centre de Recherche en Sante de Nouna
Susan Kraemer Seattle Biomedical Research Institute
Nirbhay Kumar Johns Hopkins University
Dominic Kwiatkowski Oxford University
David Lanar Walter Reed Army Institute of Research
Jean Langhorne National Institute for Medical Research
Karine Le Roch Genomics Institute of the Novartis Research Foundation
Frank Lee